Melda Saglam1, Hulya Arikan, Naciye Vardar-Yagli, Ebru Calik-Kutukcu, Deniz Inal-Ince, Sema Savci, Ali Akdogan, Mehmet Yokusoglu, Ergun Baris Kaya, Lale Tokgozoglu. 1. Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation (Drs Saglam, Arikan, Vardar-Yagli, and Inal-Ince, Ms Calik-Kutukcu), Faculty of Medicine, Department of Internal Medicine, Unit of Rheumatology (Dr Akdogan), and Faculty of Medicine, Department of Cardiology (Drs Kaya and Tokgozoglu), Hacettepe University, Ankara, Turkey; School of Physiotherapy and Rehabilitation, Dokuz Eylul University, Izmir, Turkey (Dr Savci); Department of Cardiology, Gülhane Military Medicine Academy, Ankara, Turkey (former) (Dr Yokusoglu).
Abstract
PURPOSE: The purpose of this study was to investigate the effects of inspiratory muscle training (IMT) on functional capacity, respiratory muscle strength, pulmonary function, quality of life, and fatigue and dyspnea perception in patients with pulmonary arterial hypertension (PAH). METHODS:Twenty-nine clinically stable PAH patients were included in this study. These patients were randomly assigned to a 6-week IMT program (14 patients) or to a sham IMT protocol (15 patients). Before and after the treatment, pulmonary function, respiratory muscle strength, functional capacity, dyspnea and fatigue perception, and quality of life were evaluated. RESULTS: There were significant increases in maximal inspiratory and expiratory pressure, forced expiratory volume in 1 second (% predicted) and 6-minute walk distance in the IMT group compared with the control group (P < .05). There were significant decreases in the Fatigue Severity Scale score, Modified Medical Research Council dyspnea scores, and Nottingham Health Profile emotional reactions subscale in the IMT group compared with the control group (P < .05). CONCLUSIONS:Inspiratory muscle training promotes significant improvements in respiratory muscle strength and functional capacity, thus resulting in a reduction of dyspnea during activities of daily living and less fatigue in PAH patients. Inspiratory muscle training is a clinically practical treatment for PAH without any complications.
RCT Entities:
PURPOSE: The purpose of this study was to investigate the effects of inspiratory muscle training (IMT) on functional capacity, respiratory muscle strength, pulmonary function, quality of life, and fatigue and dyspnea perception in patients with pulmonary arterial hypertension (PAH). METHODS: Twenty-nine clinically stable PAH patients were included in this study. These patients were randomly assigned to a 6-week IMT program (14 patients) or to a sham IMT protocol (15 patients). Before and after the treatment, pulmonary function, respiratory muscle strength, functional capacity, dyspnea and fatigue perception, and quality of life were evaluated. RESULTS: There were significant increases in maximal inspiratory and expiratory pressure, forced expiratory volume in 1 second (% predicted) and 6-minute walk distance in the IMT group compared with the control group (P < .05). There were significant decreases in the Fatigue Severity Scale score, Modified Medical Research Council dyspnea scores, and Nottingham Health Profile emotional reactions subscale in the IMT group compared with the control group (P < .05). CONCLUSIONS: Inspiratory muscle training promotes significant improvements in respiratory muscle strength and functional capacity, thus resulting in a reduction of dyspnea during activities of daily living and less fatigue in PAH patients. Inspiratory muscle training is a clinically practical treatment for PAH without any complications.
Authors: Daniel H Craighead; Dallin Tavoian; Kaitlin A Freeberg; Josie L Mazzone; Jennifer R Vranish; Claire M DeLucia; Douglas R Seals; E Fiona Bailey Journal: J Appl Physiol (1985) Date: 2022-09-15
Authors: Ahmad Sabbahi; Richard Severin; Cemal Ozemek; Shane A Phillips; Ross Arena Journal: Expert Rev Respir Med Date: 2020-01-03 Impact factor: 3.772
Authors: Karen S W Chia; Steven G Faux; Peter K K Wong; Cameron Holloway; Hassan Assareh; Craig S McLachlan; Eugene Kotlyar Journal: BMJ Open Date: 2017-02-06 Impact factor: 2.692
Authors: Jens Spiesshoefer; Simon Herkenrath; Michael Mohr; Winfired Randerath; Izabela Tuleta; Gerhard Paul Diller; Michele Emdin; Peter Young; Carolin Henke; Anca Rezeda Florian; Ali Yilmaz; Matthias Boentert; Alberto Giannoni Journal: Biosci Rep Date: 2019-09-03 Impact factor: 3.840